The CPTAC study “Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers” has been published in Cell Reports Medicine. Congratulations to Eric and all co-authors!
News Story
News Story
The CPTAC study “Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers” has been published in Cell Reports Medicine. Congratulations to Eric and all co-authors!